guest ::
| Home > Publications database > Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study. > print |
| Home > Publications database > Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study. > print |
| 001 | 119391 | ||
| 005 | 20240228134939.0 | ||
| 024 | 7 | _ | |a 10.1038/ejcn.2013.235 |2 doi |
| 024 | 7 | _ | |a pmid:24253760 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC4234029 |2 pmc |
| 024 | 7 | _ | |a 0954-3007 |2 ISSN |
| 024 | 7 | _ | |a 1476-5640 |2 ISSN |
| 024 | 7 | _ | |a altmetric:2100840 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2017-00145 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Abbas, S. |b 0 |
| 245 | _ | _ | |a Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study. |
| 260 | _ | _ | |a New York, NY |c 2014 |b Nature Publ. Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1487316345_21592 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Prospective cohort studies have indicated that serum vitamin D levels are inversely related to risk of type 2 diabetes. However, such studies cannot determine the source of vitamin D. Therefore, we examined the association of dietary vitamin D intake with incident type 2 diabetes within the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study in a heterogeneous European population including eight countries with large geographical variation.Using a case-cohort design, 11,245 incident cases of type 2 diabetes and a representative subcohort (N=15,798) were included in the analyses. Hazard ratios (HR) and 95% confidence intervals (CIs) for type 2 diabetes were calculated using a Prentice-weighted Cox regression adjusted for potential confounders. Twenty-four-hour diet-recall data from a subsample (N=2347) were used to calibrate habitual intake data derived from dietary questionnaires.Median follow-up time was 10.8 years. Dietary vitamin D intake was not significantly associated with the risk of type 2 diabetes. HR and 95% CIs for the highest compared to the lowest quintile of uncalibrated vitamin D intake was 1.09 (0.97-1.22) (Ptrend=0.17). No associations were observed in a sex-specific analysis. The overall pooled effect (HR (95% CI)) using the continuous calibrated variable was 1.00 (0.97-1.03) per increase of 1 μg/day dietary vitamin D.This observational study does not support an association between higher dietary vitamin D intake and type 2 diabetes incidence. This result has to be interpreted in light of the limited contribution of dietary vitamin D on the overall vitamin D status of a person. |
| 536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Vitamin D |0 1406-16-2 |2 NLM Chemicals |
| 700 | 1 | _ | |a Linseisen, J. |b 1 |
| 700 | 1 | _ | |a Rohrmann, S. |b 2 |
| 700 | 1 | _ | |a Beulens, J. W. J. |b 3 |
| 700 | 1 | _ | |a Buijsse, B. |b 4 |
| 700 | 1 | _ | |a Amiano, P. |b 5 |
| 700 | 1 | _ | |a Ardanaz, E. |b 6 |
| 700 | 1 | _ | |a Balkau, B. |b 7 |
| 700 | 1 | _ | |a Boeing, H. |b 8 |
| 700 | 1 | _ | |a Clavel-Chapelon, F. |b 9 |
| 700 | 1 | _ | |a Fagherazzi, G. |b 10 |
| 700 | 1 | _ | |a Franks, P. W. |b 11 |
| 700 | 1 | _ | |a Gavrila, D. |b 12 |
| 700 | 1 | _ | |a Grioni, S. |b 13 |
| 700 | 1 | _ | |a Kaaks, R. |0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |b 14 |u dkfz |
| 700 | 1 | _ | |a Key, T. J. |b 15 |
| 700 | 1 | _ | |a Khaw, K. T. |b 16 |
| 700 | 1 | _ | |a Kühn, T. |0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe |b 17 |u dkfz |
| 700 | 1 | _ | |a Mattiello, A. |b 18 |
| 700 | 1 | _ | |a Molina-Montes, E. |b 19 |
| 700 | 1 | _ | |a Nilsson, P. M. |b 20 |
| 700 | 1 | _ | |a Overvad, K. |b 21 |
| 700 | 1 | _ | |a Quirós, J. R. |b 22 |
| 700 | 1 | _ | |a Rolandsson, O. |b 23 |
| 700 | 1 | _ | |a Sacerdote, C. |b 24 |
| 700 | 1 | _ | |a Saieva, C. |b 25 |
| 700 | 1 | _ | |a Slimani, N. |b 26 |
| 700 | 1 | _ | |a Sluijs, I. |b 27 |
| 700 | 1 | _ | |a Spijkerman, A. M. W. |b 28 |
| 700 | 1 | _ | |a Tjonneland, A. |b 29 |
| 700 | 1 | _ | |a Tumino, R. |b 30 |
| 700 | 1 | _ | |a van der A, D. L. |b 31 |
| 700 | 1 | _ | |a Zamora-Ros, R. |b 32 |
| 700 | 1 | _ | |a Sharp, S. J. |b 33 |
| 700 | 1 | _ | |a Langenberg, C. |b 34 |
| 700 | 1 | _ | |a Forouhi, N. G. |b 35 |
| 700 | 1 | _ | |a Riboli, E. |b 36 |
| 700 | 1 | _ | |a Wareham, N. J. |b 37 |
| 773 | _ | _ | |a 10.1038/ejcn.2013.235 |g Vol. 68, no. 2, p. 196 - 202 |0 PERI:(DE-600)2004986-9 |n 2 |p 196 - 202 |t European journal of clinical nutrition |v 68 |y 2014 |x 1476-5640 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:119391 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2014 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J CLIN NUTR : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l Epidemiologie von Krebserkrankungen |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|